Cambridge MedAI Seminar: “AI-derived Whole-liver PDFF for Quantitative Assessment of Hepatic Steatosis” and “TMoE: Task-Conditioned Mixture-of-Experts with Task-Query Heads for Medical Image Classification”

Thursday 28 April 2026, 12:00 -13:00 at the Jeffrey Cheah Biomedical Centre, Main Lecture Theatre.

Professor Grant Stewart leads national recommendations on kidney cancer care

Professor Grant Stewart has led the development of the first NICE guideline on improving the diagnosis and management of kidney cancer

Cambridge MedAI Seminar: “AI Based Early Detection in Hereditary Diffuse Gastric Cancer Patients” and “From radiology reports to early prognostic markers: benchmarking LLMs in chronic liver disease”

Tuesday 24 March 2026, 12-1pm at the Jeffrey Cheah Biomedical Centre (Main Lecture Theatre), University of Cambridge

Speaker spotlight: Dr Inês Prata Machado

Our very own Inês Machado is featured in a Cambridge Festival Speaker Spotlight article

International research team receives $1 million to use AI to improve ovarian cancer care

The Global Ovarian Cancer Research Consortium has awarded its inaugural AI Accelerator Grant to an international team of researchers from Cambridge, Canada, Australia and the United States.

The Cambridge Festival 2026

The Cambridge Festival cancer zone will take place on Saturday 21st March 2026, 11:00 – 16:00 in the CAST building on the Biomedical Campus.

Cambridge MedAI Seminar: “CT-Based Deep Learning Model for Predicting Immunotherapy Efficacy in Non-Small Cell Lung Cancer Patients” and “Biomechanically-Guided Deep Learning for Brain Tumour Surgery”

Tuesday 24 February 2026, 12-1pm at the Jeffrey Cheah Biomedical Centre (Main Lecture Theatre), University of Cambridge

Cancer Molecular Diagnostics Laboratory becomes an accredited medical laboratory

The Cancer Molecular Diagnostics Laboratory (CMDL) has been awarded ISO 15189 accreditation

News